Changes in expression of transferrin, insulin-like growth factor 1, and interleukin 4 receptors after irradiation of cells of primary malignant brain tumor cell lines

Radiation Research

Volumn 160, Issue 2, 2003, Pages 224-231

  Kim, Ki Uk ^a   Xiao, Jing ^a   Ni, Hsiao Tzu ^a   Cho, Kwan H ^a   Spellman, Stephen R ^a   Low, Walter C ^a   Hall, Walter A ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Box 96 MAYO ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOTOXIN; INTERLEUKIN 4 RECEPTOR; SOMATOMEDIN C; TRANSFERRIN RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN CANCER; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; FLOW CYTOMETRY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY;

EID: 0042303765     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3040     Document Type: Article

References (57)

1. W. A. Hall, Targeted toxin therapy. In Advances in Neuro-Oncology II (P. L. Kornblith and M. D. Walker, Eds.), pp. 505-516. Futura Publishing Co., Armonk, 1997.
2. W. A. Hall and Ø. Fodstad, Immunotoxins and central nervous system neoplasia. J. Neurosurg. 76, 1-12 (1992).
3. C. B. Siegall, Targeted toxins as anticancer agents. Cancer 74, 1006-1012 (1994).
4. I. Pastan, M. C. Willingham and D. J. P. FitzGerald, Immunotoxins. Cell 47, 641-648 (1986).
5. H. N. Antoniades, T. Galanopoulos, J. Neville-Golden and M. Maxwell, Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas: In vivo studies using in situ hybridization and immunocytochemistry. Int. J. Cancer 50, 215-222 (1992).
6. B. A. Jabaari, H. M. Ladyman, M. Larche, G. B. Sivolapenko, A. A. Epenetos and M. A. Ritter, Elevated expression of the interleukin 4 receptor in carcinoma: A target for immunotherapy? Br. J. Cancer 59, 910-914 (1989).
7. R. K. Puri, P. Leland, R. J. Kreitman and I. Pastan, Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein. Int. J. Cancer 58, 574-581 (1994).
8. L. Recht, C. O. Torres, T. W. Smith, V. Raso and T. W. Griffin, Transferrin receptor in normal and neoplastic brain tissue: Implications for brain-tumor immunotherapy. J. Neurosurg. 72, 941-945 (1990).
9. B. F. Haynes, M. Hemler, T. Cotner, D. L. Mann, G. S. Eisenbarth, J. L. Strominger and A. S. Fauci, Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation. J. Immunol. 127, 347-351 (1981).
10. M. Colombatti, M. Bisconti, L. Dell'Arciprete, M. A. Gerosa and G. Tridente, Sensitivity of human glioma cells to cytotoxic heteroconjugates. Int. J. Cancer 42, 441-448 (1988).
11. W. A. Hall, A. Godal, S. Juell and O. Fodstad, In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme. J. Neurosurg. 76, 838-844 (1992).
12. V. G. Johnson, C. Wrobel, D. Wilson, J. Zovickian, L. Greenfield, E. H. Oldfield and R. Youle, Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia. J. Neurosurg. 70, 240-248 (1989).
13. J. Zovickian, V. G. Johnson and R. J. Youle, Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin. J. Neurosurg. 66, 850-861 (1987).
14. R. K. Puri, D. S. Hoon, P. Leland, P. Snoy, R. W. Rand, I. Pastan and R. J. Kreitman, Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated pseudomonas exotoxin for therapy of malignant astrocytoma. Cancer Res. 56, 5631-5637 (1996).
15. lyn tyrosine kinase by ionizing radiation. J. Biol. Chem. 269, 20739-20743 (1994).
16. T. Matsuo, A. Ohtsuru, M. Ito, K. Komatsu, Y. Okumura, H. Numba, S. Yamashita and I. Sekine, Inhibition of epidermal growth factor binding system by ionizing radiation in A431 human squamous carcinoma cells. Cancer Lett. 89, 153-159 (1995).
17. R. R. Weichselbaum, D. E. Hallahan, V. Sukhatme, A. Dritschilo, M. L. Sherman and D. W. Kufe, Biological consequences of gene regulation after ionizing radiation exposure. J. Natl. Cancer Inst. 83, 480-484 (1991).
18. L. C. Goumnerova and A. Guha, Oncogenes and growth factors in human astrocytomas. In Astrocytomas: Diagnosis, Treatment, and Biology (P. M. Black, W. C. Schoene and L. A. Lampson, Eds.), pp. 211-227. Blackwell Scientific, Boston, 1993.
19. N. Shitara, K. Kitamura, T. Wada, H. Nakamura and K. Takakura, Transferrin receptor molecules in human cell lines derived from the CNS malignant gliomas: Immunohistochemical and flow-cytometric study. Acta Histochem. Cytochem. 22, 275-288 (1989).
20. D. Y. Wen, W. A. Hall and Ø. Fodstad, Rapid detection of transferrin receptor expression on glioma cell lines by using magnetic microspheres. Neurosurgery 33, 878-881 (1993).
21. S. Gammeltoft, R. Ballotti, A. Kowalski, B. Westermark and E. van Obberghen, Expression of two types of receptor for insulin-like growth factors in human malignant glioma. Cancer Res. 48, 1233-1237 (1988).
22. S. R. Husain, N. Behari, R. J. Kreitman, I. Pastan and R. K. Puri, Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy. Cancer Res. 58, 3649-3653 (1998).
23. D. W. Laske, O. Ilercil, A. Akbasak, R. J. Youle and E. H. Oldfield, Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice. J. Neurosurg. 80, 520-526 (1994).
24. Z. Fuks, A. Haimovitz-Friedman, D. E. Hallahan, D. W. Kufe and R. R. Weichselbaum, Stress response genes induced in mammalian cells by ionizing radiation. Radiat. Oncol. Investig. 1, 81-93 (1993).
25. C. N. Coleman, Beneficial liaisons: Radiobiology meets cellular and molecular biology. Radiother. Oncol. 28, 1-15 (1993).
26. D. E. Hallahan, S. Virudachalam, M. L. Sherman, E. Huberman, D. W. Kufe and R. R. Weichselbaum, Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Res. 51, 4565-4569 (1991).
27. D. E. Hallahan, V. P. Sukhatme, M. L. Sherman, S. Virudachalam, D. Kufe and R. R. Weichselbaum, Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGRI and JUN. Proc. Natl. Acad. Sci. USA 88, 2156-2160 (1991).
28. R. K. Schmidt-Ullrich, K. Valerie, P. B. Fogleman and J. Walters, Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. Radiat. Res. 145, 81-85 (1996).
29. F. M. Uckun, G. L. Schieven, L. M. Tuel-Ahlgren, I. Dibirdik, D. E. Myers, J. A. Ledbetter and C. W. Song, Tyrosine phosphorylation is a mandatory proximal step in radiation-induced activation of the protein kinase C signaling pathway in human B-lymphocyte precursors. Proc. Natl. Acad. Sci. USA 90, 252-256 (1993).
30. R. K. Schmidt-Ullrich, K. C. Valerie, W. Chan and D. McWilliams, Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures. Int. J. Radiat. Oncol. Biol. Phys. 29, 813-819 (1994).
31. R. U. Peter, A. Beetz, C. Ried, G. Michel, D. van Beuningen and T. Ruzicka, Increased expression of the epidermal growth factor receptor in human epidermal keratinocytes after exposure to ionizing radiation. Radiat. Res. 136, 65-70 (1993).
32. S. Trowbridge and D. A. Shackelford, Structure and function of transferrin receptors and their relationship to cell growth. Biochem. Soc. Symp. 51, 117-129 (1986).
33. S. Kvaløy, R. Langholm, O. Kaalhus, T. Michaelsen, S. Funderud, A. Foss Abrahamsen and T. Godal, Transferrin receptor and B-lymphoblast antigen - their relationship to DNA synthesis, histology and survival in B-cell lymphomas. Int. J. Cancer 33, 173-177 (1984).
34. L. A. Martell, A. Agrawal, D. A. Ross and K. M. Muraszko, Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Cancer Res. 53, 1348-1353 (1993).
35. C. Schneider, R. Sutherland, R. Newman and M. Greaves, Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9. J. Biol. Chem. 257, 8516-8522 (1982).
36. D. G. Baskin, B. J. Wilcox, D. P. Figlewicz and D. M. Dorsa, Insulin and insulin-like growth factors in the CNS. Trends Neurosci. 11, 107-111 (1988).
37. V. R. Sara and C. Carlsson-Skwirut, The role of the insulin-like growth factors in the regulation of brain development. Prog. Brain Res. 73, 87-99 (1988).
38. R. P. Glick, T. Lichtor and T. G. Unterman, Insulin-like growth factors in central nervous system tumors. J. Neurooncol. 35, 315-325 (1997).
39. T. Lichtor, M. A. Kurpakus and M. E. Gurney, Differential expression of insulin-like growth factor II in human meningiomas. Neurosurgery 29, 405-410 (1991).
40. P. Prisell, L. Persson, J. Boethius and V. Sara, Somatomedins in tumour cyst fluid, cerebrospinal fluid, and tumour cytosol in patients with glial tumours. Acta Neurochir. (Wien) 89, 48-52 (1987).
41. C. Sandberg, C. Engberg, M. Lake, H. von Holst and V. R. Sara, The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma. Neurosci. Lett. 93, 114-119 (1988).
42. S. Gammeltoft, G. K. Haselbacher, R. E. Humbel, M. Fehlmann and E. van Obberghen, Two types of receptor for insulin-like growth factors in mammalian brain. EMBO J. 4, 3407-3412 (1985).
43. V. R. Sara, K. Hall, H. von Holtz, R. Humbel, B. Sjogren and L. Wetterberg, Evidence for the presence of specific receptors for insulin-like growth factors 1 (IGF-1) and 2 (IGF-2) and insulin throughout the adult human brain. Neurosci. Lett. 34, 39-44 (1982).
44. J. Inobe, A. J. Slavin, Y. Komagata, Y. Chen, L. Liu and H. L. Weiner, IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28, 2780-2790 (1998).
45. W. E. Paul, Interleukin-4: A prototypic immunoregulatory lymphokine. Blood 77, 1859-1870 (1991).
46. T. Yokota, T. Otsuka, T. Mosmann, J. Banchereau, T. DeFrance, D. Blanchard, J. E. De Vries, F. Lee and K. I. Arai, Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc. Natl. Acad. Sci. USA 83, 5894-5898 (1986).
47. N. I. Obiri, J. P. Siegel, F. Varricchio and R. K. Puri, Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin. Exp. Immunol. 95, 148-155 (1994).
48. R. I. Tepper, P. K. Pattengale and P. Leder, Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57, 503-512 (1989).
49. K. Totpal and B. B. Aggarwal, Interleukin 4 potentiates the anti-proliferative effects of tumor necrosis factor on various tumor cell lines. Cancer Res. 51, 4266-4270 (1991).
50. J. W. Lowenthal, B. E. Castle, J. Christiansen, J. Schreurs, D. Rennick, N. Arai, P, Hoy, Y. Takebe and M. Howard, Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells. J. Immunol. 140, 456-464 (1988).
51. J. Ohara, Interleukin-4: Molecular structure and biochemical characteristics, biological function, and receptor expression. In The Year in Immunology 1988. Immunoregulatory Cytokines and Cell Growth (J. M. Cruse and R. E. Lewis, Jr., Eds.), pp. 126-159. Karger, Basel, 1989.
52. J. Ohara and W. E. Paul, Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage. Nature 325, 537-540 (1987).
53. D. Keegan, K. Nelms, M. White, L. M. Wang, J. H. Pierce and W. E. Paul, An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76, 811-820 (1994).
54. J. J. Ryan, L. J. McReynolds, A. Keegan, L. H. Wang, E. Garfein, P. Rothman, K. Nelms and W. E. Paul, Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4, 123-132 (1996).
55. K. H. Cho, W. A. Hall, B. J. Gerbi, P. D. Higgins, W. A. McGuire and H. B. Clark, Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int. J. Radiat. Oncol. Biol. Phys. 45, 1133-1141 (1999).
56. K. U. Kim, D. A. Vallera, H. T. Ni, K. H. Cho, W. C. Low and W. A. Hall, In vitro efficacy of recombinant diphtheria toxin-murine interleukin-4 immunoconjugate on mouse glioblastoma and neuroblastoma cell lines and the additive effect of radiation. Neurosurg. Focus 9, 5 (2000).
57. R. H. Bobo, D. W. Laske, A. Akbasak, P. F. Morrison, R. L. Dedrick and E. H. Oldfield, Convection-enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sci. USA 91, 2076-2080 (1994).